Piper Jaffray Starts Fulgent Genetics (FLGT) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/10/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- FedEx pilots ratify new collective bargaining agreement
- The real reason Meta shares are surging has nothing to do with its new AI model
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
BTIG Starts Fulgent Genetics (FLGT) at Buy
October 24, 2016 7:32 AM EDTBTIG initiated coverage on Fulgent Genetics (NASDAQ: FLGT) with a Buy rating and a price target of $15.
Analyst Karen Koski said, "While the genetic testing market is not without challenges and competition is formidable, we believe Fulgents proprietary technology platform drives multiple sustainable... More
Credit Suisse Starts Fulgent Genetics (FLGT) at Outperform
October 24, 2016 6:30 AM EDTCredit Suisse initiates coverage on Fulgent Genetics (NASDAQ: FLGT) with a Outperform rating and a price target of $13.00.
Analyst Erin Wilson commented, "FLGT is a rapidly-growing genetic testing company, leveraging a proprietary technology platform to provide physicians with relevant diagnostic information. Its analytics platform... More
